People with HIV who smoke cigarettes non-daily

ABSTRACT

Cigarette smoking is a leading cause of mortality in people with HIV (PWH) in the United States (US). A rising proportion of US tobacco users smoke non-daily, a phenomenon that is common among PWH. PWH who smoke non-daily may be attractive targets for cessation efforts, and, thus, a fuller understanding of non-daily smoking in PWH is important. We merged datasets from two randomized controlled tobacco treatment trials for PWH conducted in three cities from 2014-2020. The final dataset included 872 PWH. We analyzed sociodemographic characteristics and behavioral measures, such as nicotine dependence, motivation to quit, anxiety, and other substance use for associations with non-daily smoking, and we assessed non-daily smoking as a predictor of cessation. 13.4% of the sample smoked non-daily. In multivariable analyses, non-White race, higher anxiety, and higher motivation to quit were associated with non-daily smoking. PWH who smoked non-daily had 2.14 times the odds of those who smoked daily of quitting at six-months (95% C.I.:1.30-3.51, P=0.002). PWH who smoke non-daily differ in some demographic and behavioral characteristics from those who smoke daily. PWH reporting non-daily smoking were more likely to quit in our trials and targeting them should be a priority of future cessation efforts.

KEYWORDS:

• HIV
• tobacco
• cigarette
• smoking
• non-daily

Acknowledgement

This study was presented in part at the Sigma Xi Annual Meeting and Student Research Conference, November 4-7, 2021 (over Zoom), and at the 28th Annual Meeting of the Society for Research on Nicotine and Tobacco, March 15-18, 2022 in Baltimore, Maryland.

Data availability statement

Data access requests may be submitted in writing to the corresponding author.

Disclosure statement

Dr. Shuter has received financial compensation for the development of educational materials and delivering oral presentations from the Northeast/Caribbean AIDS Education and Training Center and from the ObG Project. No potential conflict of interest was reported by the other author(s).

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

This work was supported by awards 1R01DA036445 (JS) from the National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA), 1R01CA192954 (JS and CAS) from the National Institutes of Health (NIH)/National Cancer Institute (NCI), and by the Einstein-Rockefeller-CUNY Center for AIDS Research (P30-AI124414) which is supported by the following NIH co-funding and participating institutes and centers: NIAID, NCI, NICHD, NHBL, NIDA, NIMH, NIA, FIC and OAR. None of these sources were involved in the design, analysis, data interpretation, writing, or decision to publish the completed manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse, the National Cancer Institute, or the National Institutes of Health.